Ambu A/S
CSE:AMBU B

Watchlist Manager
Ambu A/S Logo
Ambu A/S
CSE:AMBU B
Watchlist
Price: 87.5 DKK 1.45%
Market Cap: 20.6B DKK

Ambu A/S
Revenue

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Ambu A/S
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Ambu A/S
CSE:AMBU B
Revenue
kr6B
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
N/A
GN Store Nord A/S
CSE:GN
Revenue
kr17.1B
CAGR 3-Years
-1%
CAGR 5-Years
6%
CAGR 10-Years
8%
Demant A/S
CSE:DEMANT
Revenue
kr22.6B
CAGR 3-Years
7%
CAGR 5-Years
11%
CAGR 10-Years
9%
V
ViroGates A/S
CSE:VIRO
Revenue
kr5m
CAGR 3-Years
-22%
CAGR 5-Years
7%
CAGR 10-Years
N/A
No Stocks Found

Ambu A/S
Glance View

Market Cap
20.6B DKK
Industry
Health Care

Ambu A/S, a Danish company rooted in innovation, has carved a niche in the global healthcare sector through its specialized medical devices. Founded in 1937, Ambu started with a simple mission of improving patient care and has stayed true to that vision by continuously advancing their portfolio. The company's journey began with the invention of the resuscitator bag, a revolutionary product that remains a staple in emergency and hospital settings today. Over the years, Ambu has focused strategically on three main segments: Anesthesia, Patient Monitoring & Diagnostics, and Visualisation, each playing a crucial role in the broader healthcare ecosystem. These segments allow Ambu to develop devices that enhance diagnostic procedures, improve safety, and increase efficiency in medical settings, ultimately saving lives and optimizing healthcare delivery. Ambu’s business model capitalizes primarily on innovation-driven sales, with a strong emphasis on disposable medical devices which are gaining popularity due to hygiene concerns and regulatory trends favoring single-use technologies. These products include their flagship single-use endoscopes, marketed under the brand name "Ambu aScope," which significantly reduce the risk of cross-contamination while providing high-quality diagnostic images. The company's revenue model is built on a B2B approach, dealing directly with hospitals, clinics, and other healthcare providers, ensuring a steady flow of sales through long-term contracts and partnerships. Through constant reinvestment into R&D and strategic acquisitions, Ambu sustains its market leadership, driving growth by addressing the evolving needs of the healthcare industry and setting standards in patient care solutions globally.

AMBU B Intrinsic Value
116.64 DKK
Undervaluation 25%
Intrinsic Value
Price

See Also

What is Ambu A/S's Revenue?
Revenue
6B DKK

Based on the financial report for Sep 30, 2025, Ambu A/S's Revenue amounts to 6B DKK.

What is Ambu A/S's Revenue growth rate?
Revenue CAGR 5Y
11%

Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Ambu A/S have been 11% over the past three years , 11% over the past five years .

Back to Top